If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

This week’s most popular album in Canada across all genres, ranked by album sales, audio on-demand streaming activity and digital sales of tracks from albums as compiled by Nielsen Music. The ...

A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...

Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and development efforts. Historically, oncology and immunology were the ...

“The phase 2b QUALITY study is the first human study to demonstrate that older patients who are overweight or have obesity and receiving only a Wegovy (semaglutide) GLP-1 RA are at higher risk ...

Demand for weight-loss medications, including popular brands like Ozempic and Wegovy, continues to rise. A recent study revealed that one in eight Americans has used or is currently using these drugs ...

She was prescribed compound semaglutide, a cheaper, custom-made version of the active drug in Ozempic and Wegovy, in May 2022 and lost a staggering 64lbs in six months. But then she made a big ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health ...

She ended up taking a second job to afford it. When Rice reached her goal weight, she tried phasing out semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes), using smaller and ...

This class of drugs, known as glucagon-like peptide-1 receptor agonists, or GLP-1s, also includes Wegovy and Zepbound. GLP-1s were developed to treat diabetes, but they have become popular weight ...